Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 11329: Risk Factors of Thromboembolism in Patients With Left Ventricular Noncompaction

View through CrossRef
Introduction: Left ventricular noncompaction (LVNC) is a newly recognized cardiomyopathy characterized by a pattern of prominent trabeculation and deep recesses. LVNC can lead to progressive left ventricular (LV) dysfunction and thromboembolism. However, there are few reports that the factors develop thromboembolism in patients with LVNC. Purpose: This study was sought to investigate a difference of characteristics in patients with LVNC developing thromboembolism. Methods: We retrospectively studied 43 patients (age 61 ± 17 years, 32 male) fulfilling the diagnostic criteria of LVNC out of 7842 adults patients (ejection fraction (EF)≦60%) undergoing echocardiography in our hospital between 2012 and 2015. A thickness of the noncompacted endocardial and the compacted epicardial layers was measured at the site of maximal thickness to calculate the ratio of noncompacted to compacted layer (NC/C). The LV wall was divided into five segments (apical, inferior, lateral, anterior and septal) to describe the location of the noncompacted segments. We defined the diagnostic criteria of LVNC as a presence of prominent trabeculation and deep recesses of LV on more than one segment and a maximal end systolic ratio of NC/C≧2.0. Results: LVEF was 38.0 ± 13.0%, LV end-diastolic diameter was 60.0 ± 9.5mm and left atrial diameter (LAD) was 43.8 ± 8.8 mm, respectively. Eight patients (18.6%) were complicated with thromboembolism. There were no significant difference between the patients with thromboembolism and without them on atrial fibrillation, EF and the dilation LAD. The multivariate analysis showed that the patients with thromboembolism had a significantly larger prevalence of patients with a pattern of prominent trabeculation and deep recesses of LV on more than two segments (Odds ratio 6.964, P=0.050) and the height of noncompacted layer ≧ 15 mm (Odds ratio 4.879, P=0.049). Conclusions: The findings such as more than two segments with a pattern of prominent trabeculation and deep recesses of LV and the height of noncompacted layer ≧ 15mm on echocardiography were associated with thromboembolism in patients with LVNC. Anticoagulants should be considered to prevent the patients from thromboembolism regardless of LV function and arrhythmia.
Title: Abstract 11329: Risk Factors of Thromboembolism in Patients With Left Ventricular Noncompaction
Description:
Introduction: Left ventricular noncompaction (LVNC) is a newly recognized cardiomyopathy characterized by a pattern of prominent trabeculation and deep recesses.
LVNC can lead to progressive left ventricular (LV) dysfunction and thromboembolism.
However, there are few reports that the factors develop thromboembolism in patients with LVNC.
Purpose: This study was sought to investigate a difference of characteristics in patients with LVNC developing thromboembolism.
Methods: We retrospectively studied 43 patients (age 61 ± 17 years, 32 male) fulfilling the diagnostic criteria of LVNC out of 7842 adults patients (ejection fraction (EF)≦60%) undergoing echocardiography in our hospital between 2012 and 2015.
A thickness of the noncompacted endocardial and the compacted epicardial layers was measured at the site of maximal thickness to calculate the ratio of noncompacted to compacted layer (NC/C).
The LV wall was divided into five segments (apical, inferior, lateral, anterior and septal) to describe the location of the noncompacted segments.
We defined the diagnostic criteria of LVNC as a presence of prominent trabeculation and deep recesses of LV on more than one segment and a maximal end systolic ratio of NC/C≧2.
Results: LVEF was 38.
0 ± 13.
0%, LV end-diastolic diameter was 60.
0 ± 9.
5mm and left atrial diameter (LAD) was 43.
8 ± 8.
8 mm, respectively.
Eight patients (18.
6%) were complicated with thromboembolism.
There were no significant difference between the patients with thromboembolism and without them on atrial fibrillation, EF and the dilation LAD.
The multivariate analysis showed that the patients with thromboembolism had a significantly larger prevalence of patients with a pattern of prominent trabeculation and deep recesses of LV on more than two segments (Odds ratio 6.
964, P=0.
050) and the height of noncompacted layer ≧ 15 mm (Odds ratio 4.
879, P=0.
049).
Conclusions: The findings such as more than two segments with a pattern of prominent trabeculation and deep recesses of LV and the height of noncompacted layer ≧ 15mm on echocardiography were associated with thromboembolism in patients with LVNC.
Anticoagulants should be considered to prevent the patients from thromboembolism regardless of LV function and arrhythmia.

Related Results

Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
IMAGING DIAGNOSIS OF NONCOMPACTION OF VENTRICULAR MYOCARDIUM AND ITS CLINICAL SIGNIFICANCE
IMAGING DIAGNOSIS OF NONCOMPACTION OF VENTRICULAR MYOCARDIUM AND ITS CLINICAL SIGNIFICANCE
Objectives To investigate clinical and imaging features of the noncompaction of ventricular myocardium, to reduce misdiagnosis and achieve early prevention and tr...
Hydatid Cyst of The Orbit: A Systematic Review with Meta-Data
Hydatid Cyst of The Orbit: A Systematic Review with Meta-Data
Abstarct Introduction Orbital hydatid cysts (HCs) constitute less than 1% of all cases of hydatidosis, yet their occurrence is often linked to severe visual complications. This stu...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract Introduction Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Direct costs for treatment of venous thromboembolism complication 90-day after surgery
Direct costs for treatment of venous thromboembolism complication 90-day after surgery
Study object: Describe the direct treatment costs due to venous thromboembolism complications 90 days after surgery by using national health insurance reimbursement database. Patie...

Back to Top